Literature DB >> 19720970

Prostate cancer screening; is this a teachable moment?

Otis W Brawley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19720970     DOI： 10.1093/jnci/djp310

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S).

Authors:  Brice A P Wilson; Haofan Wang; Benjamin A Nacev; Ronnie C Mease; Jun O Liu; Martin G Pomper; William B Isaacs
Journal:  Mol Cancer Ther       Date:  2011-03-25       Impact factor: 6.261

2.  Factors influencing men's decisions regarding prostate cancer screening: a qualitative study.

Authors:  Jeanne M Ferrante; Eric K Shaw; John G Scott
Journal:  J Community Health       Date:  2011-10

Review 3.  Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.

Authors:  Eric Chamot; Sibylle Kristensen; Jeffrey S A Stringer; Mulindi H Mwanahamuntu
Journal:  BMC Womens Health       Date:  2010-04-01       Impact factor: 2.809

Review 4.  Meeting the global demands of epidemiologic transition - the indispensable role of cancer prevention.

Authors:  Silvia Franceschi; Christopher P Wild
Journal:  Mol Oncol       Date:  2012-11-17       Impact factor: 6.603

5.  The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.

Authors:  Bret T Howrey; Yong-Fang Kuo; Yu-Li Lin; James S Goodwin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-05-04       Impact factor: 6.053

6.  Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.

Authors:  Rogier P J Schroeder; W M van Weerden; E P Krenning; C H Bangma; S Berndsen; C H Grievink-de Ligt; H C Groen; S Reneman; E de Blois; W A P Breeman; M de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-23       Impact factor: 9.236
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.